Evidence map›Paper›PMID 36378715›Full record

ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2023

Risk factors for percutaneous left ventricular assist device explant complications.

Jason P Schott, Akash Rusia, Stephen Lynch, Adam Tawney, Syed F Mustafa, Abdalla K Balla, Ivan D Hanson

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Risk factors for percutaneous left ventricular assist device explant complications.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jason P SchottDepartment of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Royal Oak, Michigan, USA.ORCID 0000-0001-6807-8240
Akash RusiaDepartment of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Royal Oak, Michigan, USA.
Stephen LynchDepartment of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Royal Oak, Michigan, USA.
Adam TawneyDepartment of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Royal Oak, Michigan, USA.ORCID 0000-0001-7803-3126
Syed F MustafaDepartment of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Royal Oak, Michigan, USA.
Abdalla K BallaDepartment of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Royal Oak, Michigan, USA.
Ivan D HansonDepartment of Cardiovascular Medicine, Beaumont Hospital, Royal Oak, Royal Oak, Michigan, USA.
Beaumont Hospital, Royal Oak · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPercutaneous left ventricular assist device (pLVAD) explant remains nonstandardized with potential complications of bleeding and thrombosis. Explant settings include percutaneous techniques in the catheterization laboratory (CL), manually at bedside (MB), and surgically in the operating room (OR).

objectiveIdentify high-risk features for explant-related complications, including indication for support, setting, and technique.

methodsPostexplant bleeding and thrombosis/limb ischemia were identified following pLVAD removals over 2 years at a multicenter healthcare system.

resultsOf 156 patients, bleeding (n = 26 [17%]) and thrombosis (n = 9 [6%]) occurred more often in patients with the peripheral arterial disease (PAD), female gender, anemia, and cardiogenic shock. OR explants had a higher combined endpoint (4/8 [50%]) versus CL (23/133 [17%], p < 0.05) driven by transfusion. There was no difference between OR versus MB (5/15 [33%], p = 0.66) or CL versus MB (p = 0.62). In shock patients, there was no difference between CL (7/30 [23%]) versus MB (5/15 [33%], p = 0.5) and OR (4/7 [57%], p = 0.16); or MB versus OR (p = 0.38). Average length of stay was significantly lower in the CL group versus MB and OR (3.6 ± 33.2 vs. 18.4 ± 10.9 vs. 28.1 ± 15.8 days, p < 0.0001). Preclosure in shock patients (5/25 [20%] vs. 11/27 [41%], p = 0.1383) and crossover balloon occlusion technique (9/44 [16%] vs. 25/112 [22%]; p = 1) were not associated with higher combined endpoints versus control.

conclusionRisk factors for pLVAD explant complications include PAD, female gender, and cardiogenic shock. There was no difference in complication rates between explant settings among cardiogenic shock patients, but shorter length of stay when performed in the CL. There was no difference in complication rates when using the crossover balloon occlusion technique.

Indexed as

Heart-Assist DevicesThrombosisFemaleHumansRisk FactorsShock, CardiogenicTreatment Outcomeacute limb ischemiaacute myocardial infarction/STEMIbleedingcardiogenic shockmechanical circulatory supportvascular complications

Identifiers

PMID36378715
PMCPMC10099576
OpenAlexW4309096720

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.